Completed PHASE4 INTERVENTIONAL 2-arm NCT02539628

Adductor Canal Block With Continuous Infusion Versus Intermittent Boluses and Morphine Consumption

Adductor Canal Block With Continuous Infusion Versus Intermittent Boluses and Morphine Consumption: A Randomized, Triple-masked, Controlled Study

Sponsor: Bispebjerg Hospital

Conditions Postoperative Pain

Interventions ropivacaine 0.2%

Updated 7 times since 2017 Last updated: Apr 27, 2017 Started: Mar 31, 2015 Primary completion: Sep 30, 2016 Completion: Sep 30, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02539628, this PHASE4 trial focuses on Postoperative Pain and remains completed. Sponsored by Bispebjerg Hospital, it has been updated 7 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 2 earlier versions

May 2017 — Jun 2018 [monthly]

Completed PHASE4

Status: Recruiting → Completed
Jan 2017 — May 2017 [monthly]

Recruiting PHASE4

First recorded

Mar 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bispebjerg Hospital
Pia Jaeger
Smiths Medical, ASD, Inc.
University of California, San Diego

Data source: Rigshospitalet, Denmark

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Gentofte Municipality, Denmark